Literature DB >> 12393537

Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria.

Yoshiko Murakami1, Hiroshi Kosaka, Yusuke Maeda, Jun-ichi Nishimura, Norimitsu Inoue, Kazuhito Ohishi, Masaru Okabe, Junji Takeda, Taroh Kinoshita.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a hematopoietic stem cell disorder in which clonal cells defective in glycosylphosphatidylinositol (GPI) biosynthesis are expanded, leading to complement-mediated hemolysis. PNH is often associated with bone marrow suppressive conditions, such as aplastic anemia. One hypothetical mechanism for the clonal expansion of GPI(-) cells in PNH is that the mutant cells escape attack by autoreactive cytotoxic cells that are thought to be responsible for aplastic anemia. Here we studied 2 model systems. First, we made pairs of GPI(+) and GPI(-) EL4 cells that expressed major histocompatibility complex (MHC) class II molecules and various types of ovalbumin. When the GPI-anchored form of ovalbumin was expressed on GPI(+) and GPI(-) cells, only the GPI(+) cells presented ovalbumin to ovalbumin-specific CD4(+) T cells, indicating that if a putative autoantigen recognized by cytotoxic cells is a GPI-anchored protein, GPI(-) cells are less sensitive to cytotoxic cells. Second, antigen-specific as well as alloreactive CD4(+) T cells responded less efficiently to GPI(-) than GPI(+) cells in proliferation assays. In vivo, when GPI(-) and GPI(+) fetal liver cells, and CD4(+) T cells alloreactive to them, were cotransplanted into irradiated hosts, the contribution of GPI(-) cells in peripheral blood cells was significantly higher than that of GPI(+) cells. The results obtained with the second model suggest that certain GPI-anchored protein on target cells is important for recognition by T cells. These results provide the first experimental evidence for the hypothesis that GPI(-) cells escape from immunologic attack.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393537     DOI: 10.1182/blood-2002-06-1669

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Pathogenesis of selective expansion of PNH clones.

Authors:  Hideki Nakakuma; Tatsuya Kawaguchi
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

Review 2.  New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.

Authors:  Tatsuya Kawaguchi; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 3.  Immune pathophysiology of aplastic anemia.

Authors:  Shinji Nakao; Xingmin Feng; Chiharu Sugimori
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

4.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Mitsuhiro Omine; Taroh Kinoshita; Hideki Nakakuma; Jaroslaw P Maciejewski; Charles J Parker; Gérard Socié
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

Review 5.  Molecular genetics of paroxysmal nocturnal hemoglobinuria.

Authors:  Norimitsu Inoue; Yoshiko Murakami; Taroh Kinoshita
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

Review 6.  Clinical significance of acquired somatic mutations in aplastic anaemia.

Authors:  J C W Marsh; G J Mufti
Journal:  Int J Hematol       Date:  2016-03-18       Impact factor: 2.490

Review 7.  Recent advances in understanding clonal haematopoiesis in aplastic anaemia.

Authors:  Natasha Stanley; Timothy S Olson; Daria V Babushok
Journal:  Br J Haematol       Date:  2017-01-20       Impact factor: 6.998

Review 8.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

9.  Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytes.

Authors:  Yasutaka Ueda; Jun-ichi Nishimura; Yoshiko Murakami; Sachiko Kajigaya; Taroh Kinoshita; Yuzuru Kanakura; Neal S Young
Journal:  Eur J Haematol       Date:  2014-01-30       Impact factor: 2.997

10.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.